These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 16142248)

  • 21. Sensitivity and specificity of 99mTc-TRODAT-1 SPECT imaging in differentiating patients with idiopathic Parkinson's disease from healthy subjects.
    Weng YH; Yen TC; Chen MC; Kao PF; Tzen KY; Chen RS; Wey SP; Ting G; Lu CS
    J Nucl Med; 2004 Mar; 45(3):393-401. PubMed ID: 15001678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
    Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
    Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging.
    Huang WS; Lin SZ; Lin JC; Wey SP; Ting G; Liu RS
    J Nucl Med; 2001 Sep; 42(9):1303-8. PubMed ID: 11535717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Utility of dopamine transporter imaging (123-I Ioflupane SPECT) in the assessment of movement disorders].
    García Vicente AM; Vaamonde Cano J; Poblete García VM; Rodado Marina S; Cortés Romera M; Ruiz Solís S; Ibáñez Alonso R; Soriano Castrejón A
    Rev Esp Med Nucl; 2004; 23(4):245-52. PubMed ID: 15207208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies.
    Koch W; Radau PE; Hamann C; Tatsch K
    J Nucl Med; 2005 Jul; 46(7):1109-18. PubMed ID: 16000279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease.
    Ottaviani S; Tinazzi M; Pasquin I; Nothdurfter W; Tomelleri G; Fincati E; Nordera G; Moretto G; Fiaschi A; Smania N; Giorgetti P; Antonini A
    Neurol Sci; 2006 Dec; 27(6):397-401. PubMed ID: 17205224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification and visualization of defects of the functional dopaminergic system using an automatic algorithm.
    Habraken JB; Booij J; Slomka P; Sokole EB; van Royen EA
    J Nucl Med; 1999 Jul; 40(7):1091-7. PubMed ID: 10405125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two neural network classifiers in the differential diagnosis of essential tremor and Parkinson's disease by (123)I-FP-CIT brain SPECT.
    Palumbo B; Fravolini ML; Nuvoli S; Spanu A; Paulus KS; Schillaci O; Madeddu G
    Eur J Nucl Med Mol Imaging; 2010 Nov; 37(11):2146-53. PubMed ID: 20567820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of brain 99mTc-TRODAT-1 SPET for the evaluation of Parkinson's disease.
    Huang WS; Lee MS; Lin JC; Chen CY; Yang YW; Lin SZ; Wey SP
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):155-61. PubMed ID: 15129696
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CT based attenuation correction on quantitative assessment of DaTSCAN ((123)I-Ioflupane) imaging in diagnosis of extrapyramidal diseases.
    Bieńkiewicz M; Górska-Chrzastek M; Siennicki J; Gajos A; Bogucki A; Mochecka-Thoelke A; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2008; 11(2):53-8. PubMed ID: 19585455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [123I]beta-CIT and SPECT in essential tremor and Parkinson's disease.
    Asenbaum S; Pirker W; Angelberger P; Bencsits G; Pruckmayer M; Brücke T
    J Neural Transm (Vienna); 1998; 105(10-12):1213-28. PubMed ID: 9928890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Antonini A; Benti R; De Notaris R; Tesei S; Zecchinelli A; Sacilotto G; Meucci N; Canesi M; Mariani C; Pezzoli G; Gerundini P
    Neurol Sci; 2003 Oct; 24(3):149-50. PubMed ID: 14598060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients.
    Seibyl JP; Marek K; Sheff K; Zoghbi S; Baldwin RM; Charney DS; van Dyck CH; Innis RB
    J Nucl Med; 1998 Sep; 39(9):1500-8. PubMed ID: 9744331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine-transporter imaging and visuo-motor testing in essential tremor, practical possibilities for detection of early stage Parkinson's disease.
    Schwartz M; Groshar D; Inzelberg R; Hocherman S
    Parkinsonism Relat Disord; 2004 Aug; 10(6):385-9. PubMed ID: 15261882
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-tracer dopamine transporter and perfusion SPECT in differential diagnosis of parkinsonism using template-based discriminant analysis.
    Van Laere K; Casteels C; De Ceuninck L; Vanbilloen B; Maes A; Mortelmans L; Vandenberghe W; Verbruggen A; Dom R
    J Nucl Med; 2006 Mar; 47(3):384-92. PubMed ID: 16513606
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
    Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
    J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease.
    Bosman T; Van Laere K; Santens P
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):16-24. PubMed ID: 12483405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [123I]beta-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease.
    Gerschlager W; Bencsits G; Pirker W; Bloem BR; Asenbaum S; Prayer D; Zijlmans JC; Hoffmann M; Brücke T
    Mov Disord; 2002 May; 17(3):518-23. PubMed ID: 12112200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Undetectable specific striatal [¹²³I]-ioflupane binding in patients with parkinsonism.
    Petyt G; Kreisler A; Demailly F; Olivier A; Defebvre L; Semah F
    J Neurol Sci; 2014 Jun; 341(1-2):167-71. PubMed ID: 24814162
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Presynaptic nigro-striatal function in a group of Alzheimer's disease patients with parkinsonism: evidence from a dopamine transporter imaging study.
    Ceravolo R; Volterrani D; Gambaccini G; Bernardini S; Rossi C; Logi C; Tognoni G; Manca G; Mariani G; Bonuccelli U; Murri L
    J Neural Transm (Vienna); 2004 Aug; 111(8):1065-73. PubMed ID: 15254794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.